410
Participants
Start Date
July 1, 2018
Primary Completion Date
July 31, 2020
Study Completion Date
December 31, 2021
BAT8001 for injection
3.6 mg/kg, q3w, administered intravenously on day 1 of each treatment cycle, 21 days/treatment cycle.
Lapatinib
Lapatinib 1250 mg was administered orally once per day of each 21-day cycle.
Capecitabine
Capecitabine 1000 milligrams per square meter (mg/m\^2) was administered orally twice daily on Days 1-14 of each 21-day cycle.
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Anhui Provincial Hospital, Hefei
Beijing Hospital, Beijing
Beijing Shijitan Hospital, Beijing
Chinese PLA General Hospital, Beijing
Peking union medical college hospital, Beijing
Chongqing Cancer Hospital, Chongqing
The First Affiliated Hospital of Xiamen University, Xiamen
Foshan City No. 1 People's Hospital, Foshan
Cancer Center of Guangzhou Medical University, Guangzhou
Sun Yat-sen Memorial Hospital. SYSU, Guangzhou
Sun Yat-sen University Cancer Center, Guangzhou
Peking University Shenzhen Hospital, Shenzhen
Shenzhen People's Hospital, Shenzhen
The First Affiliated Hospital of Guangdong Medical University, Zhanjiang
The Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai
Liuzhou workers hospital, Liuzhou
The First Affiliated Hospital of Hainan Medical College, Haikou
Harbin Medical University Cancer Hospital, Harbin
The First Affiliated Hospital of Henan University of science and technology, Luoyang
The First Affiliated Hospital of Xixiang Medical College, Xinxiang
Hubei Cancer Hospital, Wuhan
Tongji Hospital of Tongji Medical College of HUST, Wuhan
Zhongnan Hospital of Wuhan University, Wuhan
Yichang Central Hospital, Yichang
Hunan Cancer Hospital, Changsha
Xiangya Hospital Central South University, Changsha
Jiangsu Cancer Hospital, Nanning
Affiliated Hospital of Jiangnan University, Wuxi
Yancheng City No. 1 People's Hospital, Yancheng
Jiangxi Cancer Hospital, Nanchang
The Third Hospital of Nanchang, Nanchang
Jilin Cancer Hospital, Changchun
The First Bethune Hospital of Jilin University, Changchun
Jinzhou Central Hospital, Jinzhou
Liaoning Cancer Hospital, Shenyang
General Hospital of Ningxia Medical University, Yinchuan
Shandong Cancer Hospital, Jinan
Linyi Cancer Hospital, Linyi
Weifang People's Hospital, Weifang
Fudan University Shanghai Cancer Hospital, Shanghai
Shanghai General Hospital, Shanghai
Shanghai Sixth People's Hospital, Shanghai
The Second Hospital of Anhui Medical University, Shanghai
Shanxi Cancer Hospital, Xi’an
The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an
West China Hospital of Sichuan University, Chengdu
Yunnan Cancer Hospital, Kunming
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Taizhou Hispotal of Zhejiang Province, Taizhou
Lead Sponsor
Bio-Thera Solutions
INDUSTRY